| COVID-19 |
1 |
1 |
| Residency |
0 |
0.79 |
| Severe Acute Respiratory Syndrome |
0 |
0.59 |
| Autoimmune Disease |
0 |
0.39 |
| Acute Respiratory Distress Syndrome |
0 |
0.38 |
| Medical Life |
0 |
0.22 |
| Vasculitis |
0 |
0.11 |
| Alopecia Areata |
0 |
0.1 |
| Auto-inflammatory Diseases |
0 |
0.1 |
| Child |
0 |
0.1 |
| Colorado |
0 |
0.1 |
| Concerns of Elderly |
0 |
0.1 |
| Dermatomyositis |
0 |
0.1 |
| Dermatoses |
0 |
0.1 |
| Digital of Foot |
0 |
0.1 |
| Geriatrics |
0 |
0.1 |
| Giant Cell Arteritis |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Granulomatosis |
0 |
0.1 |
| Health Care Organizations |
0 |
0.1 |
| Immunization |
0 |
0.1 |
| Inpatient Care |
0 |
0.1 |
| Lupus |
0 |
0.1 |
| Match |
0 |
0.1 |
| Pathogenesis |
0 |
0.1 |
| Raynaud Phenomenon |
0 |
0.1 |
| Tissue |
0 |
0.1 |
| Alopecia |
0 |
0.06 |
| Sarcoidosis |
0 |
0.06 |
| Scleroderma |
0 |
0.06 |